Related Experiment Video
Updated: Sep 20, 2025

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Novel ATP8B1 gene mutation in a family with progressive familial intrahepatic cholestasis
Shrutiprajna Kar1, Usha Devi2, Amit Kumar Satpathy3
1Neonatology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Insights
Progressive familial intrahepatic cholestasis type 1 (PFIC 1) is a rare genetic liver disease. A novel mutation in the ATP8B1 gene was identified in siblings with varying fatal presentations, confirming the PFIC 1 diagnosis.
Area of Science:
- Genetics
- Hepatology
- Pediatric Gastroenterology
Background:
- Progressive familial intrahepatic cholestasis (PFIC) comprises rare, heterogeneous autosomal recessive hepatobiliary disorders.
- PFIC type 1 (PFIC 1) is linked to mutations in the ATP8B1 gene, typically presenting with infantile cholestasis, pruritus, malabsorption, and progressive liver failure.
Purpose of the Study:
- To report two siblings with diverse clinical manifestations of a fatal hepatic disease.
- To identify the genetic basis of PFIC 1 in these patients.
Main Methods:
- Clinical case presentation of two siblings.
- Carrier whole-exome sequencing of parental DNA.
Main Results:
- Both siblings presented with varying clinical features of a fatal hepatic disease.
- A novel heterozygous pathogenic mutation in exon 28 of the ATP8B1 gene was identified in both parents.
Conclusions:
- The identified novel ATP8B1 mutation validates the diagnosis of PFIC 1 in the affected siblings.
- This finding highlights the genetic heterogeneity and variable clinical expressivity of PFIC 1.
Abstract:
Progressive familial intrahepatic cholestasis (PFIC) denotes a rare, heterogeneous group of hepatobiliary disorders with autosomal recessive inheritance. PFIC 1 results from a genetic mutation involving the ATP8B1 gene on chromosome 18. It classically manifests with infantile-onset cholestasis with pruritus and malabsorption, progressing to hepatic failure in the first decade of life. There are a few other minor manifestations described previously in the literature. We report two siblings with varying clinical presentations of a fatal hepatic disease. Carrier whole-exome sequencing detected a novel heterozygous pathogenic mutation in the exon 28 of the ATPBB1 gene in both parents, thus validating the diagnosis of PFIC 1.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
ATP Synthase: Mechanism
ATP Synthase: Structure
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pedigree Analysis